Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 6
1964 5
1965 2
1966 3
1967 3
1968 6
1969 1
1970 4
1971 1
1972 1
1973 2
1974 4
1975 4
1976 4
1977 3
1978 3
1979 3
1980 2
1981 8
1982 4
1983 7
1984 6
1985 5
1986 6
1987 9
1988 9
1989 11
1990 14
1991 10
1992 9
1993 6
1994 14
1995 5
1996 13
1997 9
1998 10
1999 6
2000 11
2001 13
2002 10
2003 11
2004 15
2005 14
2006 11
2007 11
2008 22
2009 16
2010 9
2011 5
2012 3
2014 1
2016 3
2017 2
2020 1
2021 3
2022 3
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Results by year

Filters applied: . Clear all
Page 1
Miller Fisher syndrome: an updated narrative review.
Noioso CM, Bevilacqua L, Acerra GM, Della Valle P, Serio M, Vinciguerra C, Piscosquito G, Toriello A, Barone P, Iovino A. Noioso CM, et al. Among authors: serio m. Front Neurol. 2023 Aug 24;14:1250774. doi: 10.3389/fneur.2023.1250774. eCollection 2023. Front Neurol. 2023. PMID: 37693761 Free PMC article. Review.
PPARgamma in Neuroblastoma.
Peri A, Cellai I, Benvenuti S, Luciani P, Baglioni S, Serio M. Peri A, et al. Among authors: serio m. PPAR Res. 2008;2008:917815. doi: 10.1155/2008/917815. PPAR Res. 2008. PMID: 18528516 Free PMC article.
Clinical application of 5alpha-reductase inhibitors.
Cilotti A, Danza G, Serio M. Cilotti A, et al. Among authors: serio m. J Endocrinol Invest. 2001 Mar;24(3):199-203. doi: 10.1007/BF03343844. J Endocrinol Invest. 2001. PMID: 11314752 Review.
The CREM system in human spermatogenesis.
Peri A, Serio M. Peri A, et al. Among authors: serio m. J Endocrinol Invest. 2000 Oct;23(9):578-83. doi: 10.1007/BF03343779. J Endocrinol Invest. 2000. PMID: 11079452 Review.
5 alpha-reductase inhibitors, chemical and clinical models.
Guarna A, Occhiato EG, Danza G, Conti A, Serio M. Guarna A, et al. Among authors: serio m. Steroids. 1998 May-Jun;63(5-6):355-61. doi: 10.1016/s0039-128x(98)00020-8. Steroids. 1998. PMID: 9618802 Review.
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study.
Tursi A, Mocci G, Cingolani L, Savarino E, Pica R, Cocco A, Zippi M, Napolitano D, Schiavoni E, Pugliese D, Scaldaferri F, Costa F, Marzo M, Serio M, Scarcelli A, Bolognini L, Bendia E, Maconi G, Cannatelli R, Piergallini S, Bodini G, Calabrese F, Ferronato A, Pranzo G, Elisei W, Monterubbianesi R, Faggiani R, Rodinò S, Sebkova L, Grossi L, Gaiani F, Dè Angelis G, Lorenzetti R, Allegretta L, Cazzato AI, Scorza S, Della Valle N, Sacco R, Forti G, Colucci R, Tonti P, Neve V, Rocco G, Sacchi C, Zampaletta C, Pagnini C, Graziani MG, Di Paolo MC, Onidi FM, Usai Satta P, Picchio M, Papa A. Tursi A, et al. Among authors: serio m. Expert Opin Pharmacother. 2023 Sep-Dec;24(14):1649-1656. doi: 10.1080/14656566.2023.2230126. Epub 2023 Jun 28. Expert Opin Pharmacother. 2023. PMID: 37358928
Anti-pan-neurofascin nodopathy: cause of fulminant neuropathy.
Acerra GM, Bevilacqua L, Noioso CM, Valle PD, Serio M, Vinciguerra C, Piscosquito G, Toriello A, Vegezzi E, Gastaldi M, Barone P, Iovino A. Acerra GM, et al. Among authors: serio m. Neurol Sci. 2024 Apr;45(4):1755-1759. doi: 10.1007/s10072-023-07297-4. Epub 2024 Jan 8. Neurol Sci. 2024. PMID: 38190082
Role of chemokines in endocrine autoimmune diseases.
Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P. Rotondi M, et al. Among authors: serio m. Endocr Rev. 2007 Aug;28(5):492-520. doi: 10.1210/er.2006-0044. Epub 2007 May 2. Endocr Rev. 2007. PMID: 17475924 Review.
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study.
Mocci G, Tursi A, Maconi G, Cataletti G, Mantia B, Serio M, Scarcelli A, Pagnini C, Graziani MG, Di Paolo MC, Pranzo G, Luppino I, Paese P, Elisei W, Monterubbianesi R, Faggiani R, Ferronato A, Perini B, Savarino E, Onidi FM, Binaghi L, Usai Satta P, Schiavoni E, Napolitano D, Scaldaferri F, Pugliese D, Pica R, Cocco A, Zippi M, Rodino S, Sebkova L, Rocco G, Sacchi C, Zampaletta C, Gaiani F, De Angelis G, Kayali S, Fanigliulo L, Lorenzetti R, Allegretta L, Scorza S, Cuomo A, Donnarumma L, Della Valle N, Sacco R, Forti G, Antonelli E, Bassotti G, Iannelli C, Luzza F, Aragona G, Perazzo P, Lauria A, Piergallini S, Colucci R, Bianco MA, Meucci C, Giorgetti G, Clemente V, Fiorella S, Penna A, De Medici A, Picchio M, Papa A. Mocci G, et al. Among authors: serio m. Expert Opin Biol Ther. 2023 Mar;23(3):293-304. doi: 10.1080/14712598.2023.2185510. Epub 2023 Mar 2. Expert Opin Biol Ther. 2023. PMID: 36843568
374 results